HK1043739A1 - Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa. - Google Patents

Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa.

Info

Publication number
HK1043739A1
HK1043739A1 HK02105172A HK02105172A HK1043739A1 HK 1043739 A1 HK1043739 A1 HK 1043739A1 HK 02105172 A HK02105172 A HK 02105172A HK 02105172 A HK02105172 A HK 02105172A HK 1043739 A1 HK1043739 A1 HK 1043739A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
pathological conditions
protozoa
yeasts
fungi
Prior art date
Application number
HK02105172A
Other languages
English (en)
Inventor
Gudrun Claus-Herz
Christoph Kessler
Gunther Bellmann
Original Assignee
Mann Gerhard Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mann Gerhard Chem Pharm Fab filed Critical Mann Gerhard Chem Pharm Fab
Publication of HK1043739A1 publication Critical patent/HK1043739A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HK02105172A 1999-04-22 2002-07-12 Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa. HK1043739A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19918324A DE19918324A1 (de) 1999-04-22 1999-04-22 Pharmazeutische Zusammensetzung wirksam gegen durch Bakterien, Viren, Pilze, Hefen und Protozoen verursachte Krankheitszustände
PCT/EP2000/000191 WO2000064429A1 (de) 1999-04-22 2000-01-13 Pharmazeutische zusammensetzung wirksam gegen durch bakterien, viren, pilze, hefen und protozoen verursachte krankheitszustände

Publications (1)

Publication Number Publication Date
HK1043739A1 true HK1043739A1 (en) 2002-09-27

Family

ID=7905524

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105172A HK1043739A1 (en) 1999-04-22 2002-07-12 Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa.

Country Status (8)

Country Link
EP (1) EP1171107B1 (xx)
AT (1) ATE284209T1 (xx)
AU (1) AU2904700A (xx)
DE (2) DE19918324A1 (xx)
ES (1) ES2234569T3 (xx)
HK (1) HK1043739A1 (xx)
PT (1) PT1171107E (xx)
WO (1) WO2000064429A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US7767216B2 (en) 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
WO2006110699A1 (en) * 2005-04-11 2006-10-19 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
EP2152304B1 (en) 2007-05-02 2018-08-22 The Regents of the University of Michigan Nanoemulsion therapeutic compositions and methods of using the same
CA3107304A1 (en) * 2018-07-24 2020-01-30 Carefusion 213, Llc Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU499860B2 (en) * 1975-04-24 1979-05-03 Honda Giken Kogyo Kabushiki Kaisha Deflector plate to equalise fuel distribution in induction gas flow
IT1082339B (it) * 1977-02-07 1985-05-21 Zambelletti Dr L Spa Composto ad attivita disinfettante e composizioni farmaceutiche che lo contengono
DE3528209C2 (de) * 1984-08-07 1993-10-28 Fresenius Ag Desinfektionsmittel
FR2616065A1 (fr) * 1987-06-02 1988-12-09 Pabst Jean Yves Aerosol pharmaceutique a base d'ammonium quaternaires
DK174702B1 (da) * 1987-09-11 2003-09-29 Syntex Llc Konserveringssystem til ophthalmiske formuleringer
FR2620698B1 (fr) * 1987-09-23 1990-08-10 Atlantic Pharma Prod Fluorure d'ammonium quaternaire et son application dans une substance inhibitrice ou destructrice d'etres vivants unicellulaires
AU6021794A (en) * 1993-01-11 1994-08-15 Allergan, Inc. Ophthalmic compositions comprising benzyllauryldimethylammonium chloride
FR2715300B1 (fr) * 1994-01-24 1996-03-29 Aromafarm Ltd Solution injectable de fluorure de benzalkonium et application à titre d'antiviral ou d'anti-infectieux.
JPH0812572A (ja) * 1994-07-01 1996-01-16 Kosakai:Kk 皮膚真菌症治療剤
JP3987593B2 (ja) * 1995-10-02 2007-10-10 サンスター株式会社 塩化ナトリウムおよび塩化マグネシウム含有口腔用組成物
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
JPH10130156A (ja) * 1996-10-30 1998-05-19 Teika Seiyaku Kk 点眼剤組成物
US5994383A (en) * 1997-11-18 1999-11-30 Woodward Laboratories, Inc. Surfactant-based antimicrobial compositions and methods for using the same
DE19837549A1 (de) * 1998-08-19 2000-02-24 Beiersdorf Ag Verwendung quaternärer Stickstoffverbindungen zur Prophylaxe und Behandlung des superinfizierten Ekzems

Also Published As

Publication number Publication date
AU2904700A (en) 2000-11-10
PT1171107E (pt) 2005-03-31
DE19918324A1 (de) 2000-10-26
DE50008908D1 (de) 2005-01-13
ATE284209T1 (de) 2004-12-15
EP1171107A1 (de) 2002-01-16
ES2234569T3 (es) 2005-07-01
EP1171107B1 (de) 2004-12-08
WO2000064429A1 (de) 2000-11-02

Similar Documents

Publication Publication Date Title
BG108443A (en) Substituted oxazoliidinones for combinational therapy
MY140488A (en) Substituted oxazolidinones and their use in the field of blood coagulation
AU2878689A (en) Locally administrable 2-amino-3-benzoyl phenylacetic acid derivatives as therapeutic compositions for inflammatory disease
EA200200059A1 (ru) Комбинация молочнокислых бактерий и ее применение для профилактики и/или лечения инфекций и воспалительных состояний
MXPA02005173A (es) Composicion farmaceutica para el tratamiento de enfermedades asociadas con disminucion de masa osea.
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
ATE178798T1 (de) Verwendung vor einfachern oder conjugiertem dextran zur herstellung eines medikaments zur vorbeugung oder verminderung des risikos einer bacterieller pathogener infektion
UA87123C2 (uk) Водна суспензія циклесоніду для аерозольного розпилення
WO2000018387A3 (en) Antibiotic compositions for treatment of the eye, ear and nose
HK1043739A1 (en) Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa.
CA2529441A1 (en) Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
TW200716142A (en) Use of azithromycin for the manufacture of a medicament for treating ocular infections
WO2002076393A3 (en) Antiagionecic, antitumor, chemopreventative agents
HK1050203A1 (en) Novel fusidic acid derivatives.
AU2002234644A1 (en) Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use
TW200701989A (en) Health care composition for oral cavity and manufacturing method thereof
PL369845A1 (en) Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
KR20000061943A (ko) 황토와 숯을 이용한 연고
CN1133711A (zh) 一种治疗、消毒药物组合物
RU94036618A (ru) Лекарственное средство для лечения железодефицитных анемий
UA32151A (uk) Склад для лікування псоріазу
UA33293A (uk) Спосіб лікування травматичних ушкоджень рогової оболонки

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20200112